ROBIN NORMAND: Open Payments
NPI 1720291636 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,854 in 84 payments from 7 companies in 2025. Trend: 2023 $1,718 · 2024 $1,573 · 2025 $1,854
Food & beverage: $1,854
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 34 | $811 |
| Gilead Sciences, Inc. | 29 | $622 |
| Merck Sharp & Dohme LLC | 13 | $250 |
| ABBVIE INC. | 4 | $82 |
| Theratechnologies Inc. | 2 | $52 |
| Invivyd Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: DOVATO, CABENUVA, ZERBAXA, Epclusa, PIFELTRO, EGRIFTA, Biktarvy, RUKOBIA.
Industry payments across AL — which companies pay providers there.
